| Bladder cancer, version 3.2020, NCCN clinical practice guidelines in oncology TW Flaig, PE Spiess, N Agarwal, R Bangs, SA Boorjian, ... Journal of the National Comprehensive Cancer Network 18 (3), 329-354, 2020 | 511 | 2020 |
| Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease? MA Borger, M Preston, J Ivanov, PWM Fedak, P Davierwala, S Armstrong, ... The Journal of thoracic and cardiovascular surgery 128 (5), 677-683, 2004 | 467 | 2004 |
| Bladder cancer, version 5.2017, NCCN clinical practice guidelines in oncology PE Spiess, N Agarwal, R Bangs, SA Boorjian, MK Buyyounouski, ... Journal of the National Comprehensive Cancer Network 15 (10), 1240-1267, 2017 | 248 | 2017 |
| NCCN guidelines insights: bladder cancer, version 5.2018 TW Flaig, PE Spiess, N Agarwal, R Bangs, SA Boorjian, ... Journal of the national comprehensive cancer network 16 (9), 1041-1053, 2018 | 241 | 2018 |
| Robot-assisted versus open radical prostatectomy: a contemporary analysis of an all-payer discharge database JJ Leow, SL Chang, CP Meyer, Y Wang, J Hanske, JD Sammon, AP Cole, ... European urology 70 (5), 837-845, 2016 | 239 | 2016 |
| A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer … KJ Pienta, MA Gorin, SP Rowe, PR Carroll, F Pouliot, S Probst, ... The Journal of urology 206 (1), 52-61, 2021 | 233 | 2021 |
| Body mass index and metastatic renal cell carcinoma: clinical and biological correlations L Albiges, AA Hakimi, W Xie, RR McKay, R Simantov, X Lin, JL Lee, ... Journal of Clinical Oncology 34 (30), 3655, 2016 | 220 | 2016 |
| Metformin use and prostate cancer risk MA Preston, AH Riis, V Ehrenstein, RH Breau, JL Batista, AF Olumi, ... European urology 66 (6), 1012-1020, 2014 | 182 | 2014 |
| Neoadjuvant chemotherapy prior to radical cystectomy for muscle‐invasive bladder cancer with variant histology MW Vetterlein, SAM Wankowicz, T Seisen, R Lander, B Löppenberg, ... Cancer 123 (22), 4346-4355, 2017 | 166 | 2017 |
| NCCN Guidelines® insights: bladder cancer, version 2.2022: featured updates to the NCCN guidelines TW Flaig, PE Spiess, M Abern, N Agarwal, R Bangs, SA Boorjian, ... Journal of the National Comprehensive Cancer Network 20 (8), 866-878, 2022 | 140 | 2022 |
| Comparison of gonadotropin-releasing hormone agonists and orchiectomy: effects of androgen-deprivation therapy M Sun, TK Choueiri, OPR Hamnvik, MA Preston, G De Velasco, W Jiang, ... JAMA oncology 2 (4), 500-507, 2016 | 136 | 2016 |
| Comparative effectiveness of trimodal therapy versus radical cystectomy for localized muscle-invasive urothelial carcinoma of the bladder T Seisen, M Sun, SR Lipsitz, F Abdollah, JJ Leow, M Menon, MA Preston, ... European urology 72 (4), 483-487, 2017 | 131 | 2017 |
| Results from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in muscle invasive bladder cancer (MIBC) undergoing cystectomy. S Gupta, G Sonpavde, CJ Weight, BA McGregor, S Gupta, BL Maughan, ... Journal of Clinical Oncology 38 (6_suppl), 439-439, 2020 | 129 | 2020 |
| Genome-wide association study identifies multiple risk loci for renal cell carcinoma G Scelo, MP Purdue, KM Brown, M Johansson, Z Wang, JE Eckel-Passow, ... Nature communications 8 (1), 15724, 2017 | 121 | 2017 |
| Effectiveness of adjuvant chemotherapy after radical nephroureterectomy for locally advanced and/or positive regional lymph node upper tract urothelial carcinoma T Seisen, RE Krasnow, J Bellmunt, M Rouprêt, JJ Leow, SR Lipsitz, ... Journal of Clinical Oncology 35 (8), 852-860, 2017 | 120 | 2017 |
| Mutational analysis of 472 urothelial carcinoma across grades and anatomic sites AH Nassar, R Umeton, J Kim, K Lundgren, L Harshman, EM Van Allen, ... Clinical Cancer Research 25 (8), 2458-2470, 2019 | 111 | 2019 |
| Primary spermatic cord tumors: disease characteristics, prognostic factors, and treatment outcomes D Rodríguez, GW Barrisford, A Sanchez, MA Preston, EI Kreydin, ... Urologic Oncology: Seminars and Original Investigations 32 (1), 52. e19-52. e25, 2014 | 105 | 2014 |
| Baseline prostate-specific antigen levels in midlife predict lethal prostate cancer MA Preston, JL Batista, KM Wilson, SV Carlsson, T Gerke, DD Sjoberg, ... Journal of Clinical Oncology 34 (23), 2705, 2016 | 99 | 2016 |
| Testicular cancer: what the radiologist needs to know EI Kreydin, GW Barrisford, AS Feldman, MA Preston American Journal of Roentgenology 200 (6), 1215-1225, 2013 | 99 | 2013 |
| The effect of body mass index on perioperative outcomes after major surgery: results from the National Surgical Quality Improvement Program (ACS‐NSQIP) 2005–2011 A Sood, F Abdollah, JD Sammon, K Majumder, M Schmid, JO Peabody, ... World journal of surgery 39 (10), 2376-2385, 2015 | 97 | 2015 |
Quoc-Dien TrinhHarvard Medical Schoolبريد إلكتروني تم التحقق منه على partners.org
